Experiences with interferon-free hepatitis C therapies: addressing barriers to adherence and optimizing treatment outcomes

Abstract Background Millions of Americans are living with hepatitis C, the leading cause of liver disease in the United States. Medication treatment can cure hepatitis C. We sought to understand factors that contribute to hepatitis C treatment completion from the perspectives of patients and provide...

Full description

Bibliographic Details
Main Authors: Avy A. Skolnik, Amanda Noska, Vera Yakovchenko, Jack Tsai, Natalie Jones, Allen L. Gifford, D. Keith McInnes
Format: Article
Language:English
Published: BMC 2019-02-01
Series:BMC Health Services Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12913-019-3904-9